1.225USD-2.08%Mkt Cap: 779.38M USDP/E: —Last update: 2026-06-01
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap779.38M USD
Enterprise Value611.57M USD
Revenue (TTM)196.12M USD
Gross Profit179.14M USD
Net Income (TTM)-83.50M USD
Revenue/Share0.2940 USD
Last Price1.225 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees258
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS3741631036
Valuation
P/E (Trailing)—
P/E (Forward)19.23
PEG—
EV/EBITDA-17.67
EV/Revenue3.12
P/S4.09
P/B3.50
EPS (TTM)-0.11
EPS (Forward)0.07
52W Range
1.04019% of range2.010
52W High2.010 USD
52W Low1.040 USD
Profitability
Gross Margin97.42%
Oper. Margin-0.46%
EBITDA Margin-17.65%
Profit Margin-45.41%
ROE-36.97%
ROA-14.64%
Growth
Revenue Growth30.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-111.04M USD
CapEx (TTM)49.00K USD
FCF Margin-46.98%
FCF Yield-11.82%
Net Debt-190.33M USD
Net Debt/EBITDA5.50
Balance Sheet
Debt/Equity0.54
Current Ratio6.78
Quick Ratio4.85
Book Value/Sh0.3570 USD
Cash/Share0.4870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1058:1000
Split DateJul 22, 2014
Analyst Consensus
Rating—
Target (Mean)3.400 USD
Target Range1.000 USD – 5.000 USD
# Analysts5
Ownership
Shares Out.641.52M
Float535.71M
Insiders0.08%
Institutions79.29%
Short Interest
Short Ratio4.3d
Short % Float10.94%
Short % Out.10.94%
Shares Short70.15M
Short (prev mo.)82.16M
Technical
SMA 501.508 (-18.8%)
SMA 2001.406 (-12.9%)
Beta0.68
S&P 52W Chg27.94%
Avg Vol (30d)13.52M
Avg Vol (10d)10.84M
Technical Indicators
RSI (14)34.6
MACD-0.0781
MACD Signal-0.0761
MACD Hist.-0.0020
BB Upper1.639 USD
BB Middle1.374 USD
BB Lower1.109 USD
BB Width38.61%
ATR (14)0.0713 USD
Vol Ratio (20d)0.45x